The stock ended at Rs 1,105.35, down 1.27 per cent on BSE. Intra-day, it dipped 3.2 per cent to Rs 1,083.75.
On NSE, shares of the company went down by 1.5 per cent to close at Rs 1,103.70.
On the volume front, 2.79 lakh shares of the company were traded on BSE and over 22 lakh shares changed hands on NSE during the day.
Healthcare firm Biocon's consolidated net profit dropped 58 per cent to Rs 148.4 crore in the quarter ended March 31, 2017, compared to the year-ago period.
Its total income in the fourth quarter was Rs 974.3 crore compared to Rs 972.7 crore in the corresponding period.
Disclaimer: No Business Standard Journalist was involved in creation of this content
